Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland

Documenti analoghi

• Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions
  di: Stencel, Katarzyna, et al.
  Pubblicazione: (2021)
• Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
  di: Nicoś, Marcin, et al.
  Pubblicazione: (2019)
• EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report
  di: Kamila, Wojas-Krawczyk, et al.
  Pubblicazione: (2013)
• The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study
  di: Krawczyk, Paweł, et al.
  Pubblicazione: (2014)
• The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
  di: Krawczyk, Paweł, et al.
  Pubblicazione: (2013)